PLI Schemes Boost India’s Pharma and Medical Device Manufacturing
What Happened
The Department of Pharmaceuticals reported that Production Linked Incentive (PLI) schemes have significantly strengthened India’s manufacturing ecosystem for bulk drugs and medical devices. According to official data, the schemes have reduced import dependence, encouraged domestic production, and supported innovation in critical healthcare sectors. The government emphasized that PLI incentives are driving investment in key raw materials, APIs, and advanced medical technologies, ensuring greater self-reliance and supply chain stability.
Key Takeaways
PLI schemes are helping India reduce reliance on imports and build a robust domestic base for pharmaceuticals and medical devices, reinforcing the country’s healthcare resilience and industrial competitiveness.